SCHEMBL12798235

SCHEMBL12798235

CSc1nnc(C)n1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12111894 0.74 — —
SCHEMBL11513663 0.73 NPC1 (0.55) —
SCHEMBL76905 0.73 — —
SCHEMBL23075084 0.72 — —
SCHEMBL9089789 0.72 — —
SCHEMBL17198678 0.72 ALDH1A1 (0.34) —
SCHEMBL974759 0.68 ALDH1A1 (0.69) —
SCHEMBL2004713 0.68 ALDH1A1 (0.59) —
SCHEMBL11376315 0.68 SMN1; SMN2 (0.52) —
SCHEMBL11337639 0.67 KMT2A (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017093543-A2 ANTI-BACTERIAL COMPOUNDS AUSPHERIX LIMITED (GB) 2017-06-08 — — WO disclosed
US-7906540-B2 Antivirals for HIV and AIDS; compounds are 2-1,2,4-triazolin-5-ones, substituted with aryl(oxy)methyl or benzylamino at position 3; use in combination with antivirals; treating drug resistance infections ROCHE PALO ALTO LLC (US) 2011-03-15 — — US disclosed
US-20080249151-A1 Non-nucleoside reverse transcriptase inhibitors ROCHE PALO ALTO LLC 2008-10-09 — — US disclosed
Send feedback